Renee D. Gala, SVP, Chief Financial Officer at Theravance Biopharma, Inc. (TBPH), sold 31,230 shares at $24.29 ($759K) on 2018-05-18, disclosed to the SEC on 2018-05-22.
Open-market sale of $759k TBPH by SVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.29 | 10,000 | $243K | 32.0% |
| 2 | $24.31 | 21,230 | $516K | 68.0% |
| Total | $24.30 avg | 31,230 | $759K | 100% |
| Filing → |
| JAZZ | SELL | 2023-05-19 | $791K | — | Filing → |
| JAZZ | SELL | 2022-12-22 | $422K | — | Filing → |
| TBPH | SELL | 2018-08-16 | $2.3M | — | Filing → |